Search
for
Sort by
Research 451–480 of 1000+
- Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
- Structure of human type II 5 alpha-reductase gene.
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- The Contribution of Endogenous and Exogenous Factors to Female Alopecia
- Abietic Acid from Resina Pini of Pinus Species as a Testosterone 5.ALPHA.-Reductase Inhibitor
- 5α-Reductase Inhibitory Components as Antiandrogens From Herbal Medicine
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art
- Medical Dermatology
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Cardiodermatology in the physician’s practice
- Compounding as a Current Therapeutic Option in Dermatology
- Crystal Structure and Synthesis of 17.ALPHA.-Acetoxy-6,7-epoxypregn-4-ene-3,20-dione
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- In That Issue: Proceedings From the Third Intercontinental Meeting of Hair Research Societies
- 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione
- History of discovery of polycystic ovary syndrome
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Rare clinical features of the Ellis van Creveld syndrome: A case report and literature review
- Serum C-19 steroid sulphates in females with clinical hyperandrogenism
- A Genetically Defined Male Counterpart of Polycystic Ovary Syndrome: Evidence for Ovarian-Independent Pathogenesis
- The Use of Anabolic Steroids by Bodybuilders in the State of Sergipe, Brazil
- Lean Women with Polycystic Ovary Syndrome
- Hormonal Therapy for Acne
- 43303 Cardiovascular Risk in Patients with Scarring and Non-Scarring Alopecias: Assessing the Current State of Evidence
- Clinical features and presentation of polycystic ovary syndrome
- What Is the Male Polycystic Ovary Syndrome Phenotype?
- HERBS THAT REDUCE ALOPECIA
- ODP408 Elevated DHEAS and Acute Hair Loss in an Adult Male with Trichorhinophalangeal Syndrome Type 1: a Case of Male PCOS